Our Blog

Farmaindustria’s Code of Conduct, dictating the treatment of personal data, establishes ethical and integrity principles to govern the operations of affiliated companies, championing transparency, responsibility, and collaboration within the sector.

By adhering to this code, Sermes CRO underscores its dedication to safeguarding and managing the personal data of patients and other stakeholders involved in such research, thereby contributing to harmonizing scientific progress with individual rights.

The integration of this code into Sermes CRO’s operational processes streamlines the interpretation and adherence to data protection regulations. It provides protocols and conduct rules, ensuring consistent criteria in handling data for clinical research projects and in the field of pharmacovigilance.

Sermes CRO’s commitment to this code reflects the company’s dedication to the highest ethical and professional standards in executing clinical trials and research services. Antonio Berlanga, the company’s CEO, emphasizes, “By aligning with this code, we affirm our commitment to the quality, transparency, and integrity of personal data across all our projects.” Berlanga highlights the decision to be the inaugural CRO to embrace Farmaindustria’s Code of Conduct as a testament to “our continuous effort to elevate standards of ethical conduct and personal data management in clinical research. We are confident that this commitment will further enhance our collaboration with the pharmaceutical industry, ensuring the trust of our clients and partners in the excellence of our services.”

Farmaindustria’s Code of Conduct, regulating personal data treatment, marks a milestone for the sector, being the first sector-specific code approved by the Spanish Data Protection Agency and a benchmark at the European level. Sermes CRO stands out as the pioneering Contract Research Organization to adopt this code since its launch in 2022, with 20 entities promoting clinical studies with medicines already on board.

Sermes CRO has been delivering clinical research services since 1997, operating as a Contract Research Organization for pharmaceutical laboratories, biotechnology companies, and independent researchers. Their services encompass clinical consulting, regulatory services, clinical trial monitoring, biostatistics, pharmacovigilance, medical writing, quality control, contracts, and Trial Master File (TMF). The company boasts a top-tier Advanced Therapies Unit and a Patient Centric Unit. Additionally, it offers technological solutions for the clinical research field, including new developments based on Artificial Intelligence to optimize processes for pharmaceutical and biotechnology companies.